FDA.reportPublic FDA data

pimavanserin 10 MG Oral Tablet

RxCUI
2049269
RxNorm name
pimavanserin 10 MG Oral Tablet
Display name
pimavanserin 10 MG Oral Tablet
Full name
pimavanserin 10 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NUPLAZIDPIMAVANSERIN TARTRATEAcadia Pharmaceuticals Inc.1e6bea44-57d6-4bac-9328-46e1ee59f83b2026-06-18Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2049269

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
1e6bea44-57d6-4bac-9328-46e1ee59f83bpimavanserin 10 MG Oral Tablet [PSN] · pimavanserin 10 MG Oral Tablet [SCD] · pimavanserin 10 mg (as pimavanserin tartrate 11.8 MG) Oral Tablet [SY]322These highlights do not include all the information needed to use NUPLAZID safely and effectively. See full prescribing information for NUPLAZID. NUPLAZID ® (pimavanserin) capsules, for oral use NUPLAZID ® (pimavanserin) tablets, for oral use Initial U.S. Approval: 201620260430